Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Prediction Intervals

Prediction Intervals

The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.

Relative Risk

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...

Hazard Ratio

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Goodness-of-Fit Test

Goodness-of-Fit Test

The goodness-of-fit test is a type of hypothesis test which determines whether the data "fits" a particular distribution. For example, one may suspect that some anonymous data may fit a binomial distribution. A chi-square test (meaning the distribution for the hypothesis test is chi-square) can be used to determine if there is a fit. The null and alternative hypotheses may be written in sentences or stated as equations or inequalities. The test statistic for a goodness-of-fit test is given as...

Sensitivity, Specificity, and Predicted Value

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Novel Role of Dexmedetomidine in the Modulation of Morphine Reward Memory via γ-Aminobutyric Acid Transporter-1.

Anesthesiology·2026

Same author

Respiratory Virus Activity - United States, July 1, 2024-June 30, 2025.

MMWR. Morbidity and mortality weekly report·2026

Same author

Spatial and spatio-temporal county-level trends in COVID-19 mortality and emergency department visits in U.S. with R-INLA.

Spatial and spatio-temporal epidemiology·2026

Same author

Estimated Burden of COVID-19 Illnesses, Medical Visits, Hospitalizations, and Deaths in the US From October 2022 to September 2024.

JAMA internal medicine·2026

Same author

Celecoxib pretreatment and nab-paclitaxel-associated acute pain syndrome in patients with breast cancer: a prospective, non-randomized controlled clinical study.

International journal of surgery (London, England)·2025

Same author

Estimating COVID-19 associated hospitalizations, ICU admissions, and in-hospital deaths averted in the United States by 2023-2024 COVID-19 vaccination: A conditional probability, causal inference, and multiplier-based approach.

Vaccine·2025

Search research articles

Related Experiment Video

Updated: Jun 28, 2025

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Out-of-Sample Fusion in Risk Prediction.

Myron Katzoff¹, Wen Zhou², Diba Khan¹

¹CDC/National Center for Health Statistics, Hyattsville, Maryland, USA.

Journal of Statistical Theory and Practice

|April 23, 2024

Summary

This study introduces a data fusion method to improve mortality risk assessment. Combining real and artificial data enhances accuracy and narrows confidence intervals for exceedance probability estimation.

Keywords:

Coverage Density ratio model Mortality Primary 62F40 Secondary 62F25 Semiparametric Threshold probabilities Tilt

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

Related Experiment Videos

Last Updated: Jun 28, 2025

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

Area of Science:

Statistics
Risk Analysis
Computational Methods

Background:

Estimating the probability of rare events, such as high mortality thresholds, is crucial for public health and safety.
Traditional statistical methods may yield wide confidence intervals due to limited real-world data.

Purpose of the Study:

To present an out-of-sample data fusion method for more precise estimation of exceedance probabilities.
To enhance the accuracy of risk assessment for mortality from specific causes.

Main Methods:

Developed an out-of-sample fusion technique combining original real data with independent computer-generated samples.
Utilized a density ratio model for estimating exceedance probabilities.
Compared the fused sample method against traditional approaches using numerical simulations.

Main Results:

The fused sample, being larger, resulted in shorter confidence intervals compared to traditional methods.
The proposed method demonstrated robust performance, maintaining good coverage even with some model misspecification.
Numerical results validated the effectiveness of the data fusion approach.

Conclusions:

Data fusion offers a powerful strategy to improve the precision of exceedance probability estimations.
The presented method provides a valuable tool for more reliable mortality risk assessment, especially for rare events.
The technique shows resilience to minor inaccuracies in model specification, enhancing its practical applicability.